期刊文献+

血清25羟基维生素D与2型糖尿病相关性分析 被引量:1

Analysis of the relationship between 25-hydroxy-vitamin D and type 2 diabetes mellitus
下载PDF
导出
摘要 目的:探讨血清25-羟基维生素D水平与2型糖尿病之间的相关性及临床意义。方法:选取2019年1月~2020年4月收治的122例2型糖尿病非骨质疏松患者作为观察组,并选取同期收治的66例骨质疏松非糖尿病患者为对照A组和体检中心的40例健康体检者为对照B组,对三组人群的血清25-羟基维生素D水平进行观察分析。结果:三组血清25-羟基维生素D水平均数不同,观察组和对照A组均数均低于对照B组,差异有统计学意义(P<0.01),但观察组与对照A组均数差异无统计学意义(P>0.05)。结论:2型糖尿病患者血清25-羟基维生素D水平明显缺乏,其程度与骨质疏松相当。 Objective This study aimed to investigate the relationship and clinical significance between serum 25 hydroxyvitamin D level(osteoporosis)and type 2 diabetes.Method From January 2019 to April 2020,122 non osteoporosis patients with type 2 diabetes admitted to our hospital were selected as the observation group,66 osteoporosis patients with no diabetes(control group A)admitted to our hospital in the same period and 40 healthy people(control group B)in the physical examination center were selected as the control group.The serum 25 hydroxyvitamin D levels of the three groups were observed and analyzed.Results The mean value of serum 25 hydroxyvitamin D in three groups was different.The mean value of observation group and control group A was lower than that of control group B(P<0.01),but there was no statistical difference between observation group and control group A(P>0.05).Conclusion The level of serum 25 hydroxyvitamin D in type 2 diabetic patients was significantly deficient,which was similar to that in osteoporosis group.
作者 由慧敏 曾春平 刘海燕 龙涛 周琳 林名润 YOU Hui-min;ZENG Chun-ping;LIU Hai-yan(Guangzhou Key Laboratory of Enhanced Recovery after Abdominal Surgery,Department of Endocrinology,The fifth affiliated hospital of Guangzhou medical university,Guangzhou,510700,China)
出处 《吉林医学》 CAS 2021年第11期2587-2590,共4页 Jilin Medical Journal
基金 广州市加速康复腹部外科重点实验室项目[项目编号:201905010004]。
关键词 25-羟基维生素D 2型糖尿病 骨质疏松 相关性 25-hydroxy-vitamin D Type 2 diabetes mellitus Osteoporosis Relativity
  • 相关文献

参考文献4

二级参考文献92

  • 1Yang W,Lu J,Weng J. Prevalence of diabetes among men and women in China[J].{H}New England Journal of Medicine,2010,(12):1090-1101.
  • 2Maalouf NM. The noncalciotropic actions of vitamin D:recent clinical developments[J].{H}Current Opinion in Nephrology and Hypertension,2008,(04):408-415.
  • 3Rabinovitch A,Suarez Pinzon WL,Sooy K. Expression of calbindin-D(28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis[J].{H}ENDOCRINOLOGY,2001,(08):3649-3655.
  • 4Gregori S,Giarratana N,Smiroldo S. A 1alpha,25-dihydroxyvitamin D(3) ananlog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice[J].{H}DIABETES,2002,(05):1367-1374.
  • 5Zhang Z,Sun L,Wang Y. Renoprotective role of the vitamin D receptor in diabetic nephropathy[J].{H}Kidney International,2008,(02):163-171.
  • 6Ishimura E,Nishizawa Y,Inaba M. Serum level of 1,25-dihydroxyvitamin D,24,25-dihydroxyvitamin D,and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure[J].{H}Kidney International,1999,(03):1019-1027.
  • 7Shoben AB,Rudser KD,de Boer IH. Association of oral calcitriol with improved survival in nondialyzed CKD[J].{H}Journal of the American Society of Nephrology,2008,(08):1613-1619.
  • 8Sanchez-Ni(n)o MD,Bozic M,Córdoba-Lanús E. Beyond proteinuria:VDR activation reduces renal inflammation in experimental diabetic nephropathy[J].{H}American Journal of Physiology Renal Physiology,2012,(06):647-657.
  • 9Zhang Z,Yuan W,Sun L. 1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-included MCP-1 expression in mesangial cells[J].{H}Kidney International,2007,(02):193-201.
  • 10Li Y,Spataro BC,Yang J. 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression[J].{H}Kidney International,2005,(04):1500-1510.

共引文献38

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部